Nimsky Christopher, Ganslandt Oliver, Von Keller Boris, Romstöck Johann, Fahlbusch Rudolf
Department of Neurosurgery, University Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany.
Radiology. 2004 Oct;233(1):67-78. doi: 10.1148/radiol.2331031352. Epub 2004 Aug 18.
To review the initial clinical experience with intraoperative high-field-strength magnetic resonance (MR) imaging of brain lesions in 200 patients.
Two hundred patients (mean age, 46.1 years; range, 7-84 years), most of whom had glioma or pituitary adenoma, were examined with a 1.5-T MR imager equipped with a rotating operating table and located in a radiofrequency-shielded operating theater. A navigation microscope placed inside the 0.5-mT zone and used in combination with a ceiling-mounted navigation system enabled integrated microscope-based neuronavigation. The extent of resection depicted at intraoperative imaging, the surgical consequences of intraoperative imaging, and the clinical practicability of the operating room setup were analyzed.
Seventy-seven resections with a transsphenoidal approach, 100 craniotomies, and 23 burr-hole procedures were performed. In 55 (27.5%) of 200 patients, intraoperative MR imaging had immediate surgical consequences (eg, extension of resection in 39% of patients with pituitary adenoma or glioma). In 108 patients the navigation system was used, and for 37 of those patients, functional imaging data were integrated into the navigation system. There was nearly no difference in quality between pre- and intraoperative images. Intraoperative workflow with intraoperative patient transport for imaging was straightforward, and imaging in most cases began less than 2 minutes after sterile covering of the surgical site. No complications resulted from high-field-strength MR imaging.
The high-field-strength MR imager was successfully adapted for intraoperative use with the integrated neuronavigation system. Intraoperative MR imaging provided valuable information that allowed intraoperative modification of the surgical strategy.
回顾200例脑病变患者术中高场强磁共振(MR)成像的初步临床经验。
200例患者(平均年龄46.1岁;范围7 - 84岁),大多数患有胶质瘤或垂体腺瘤,使用配备旋转手术台且位于射频屏蔽手术室的1.5T MR成像仪进行检查。置于0.5mT区域内并与天花板安装的导航系统结合使用的导航显微镜实现了基于显微镜的集成神经导航。分析术中成像显示的切除范围、术中成像的手术后果以及手术室设置的临床实用性。
进行了77例经蝶窦入路切除术、100例开颅手术和23例钻孔手术。在200例患者中的55例(27.5%),术中MR成像产生了直接的手术后果(例如,39%的垂体腺瘤或胶质瘤患者切除范围扩大)。108例患者使用了导航系统,其中37例患者的功能成像数据被整合到导航系统中。术前和术中图像质量几乎没有差异。术中患者转运进行成像的工作流程简单直接,大多数情况下在手术部位无菌覆盖后不到2分钟就开始成像。高场强MR成像未导致并发症。
高场强MR成像仪成功适配于术中与集成神经导航系统联合使用。术中MR成像提供了有价值的信息,使得能够在术中修改手术策略。